Literature DB >> 23188223

Risk of hepato-biliary cancer after cholecystectomy: a nationwide cohort study.

Wei-Yu Kao1, Chian-Yaw Hwang, Chien-Wei Su, Yun-Ting Chang, Jiing-Chyuan Luo, Ming-Chih Hou, Han-Chieh Lin, Fa-Yauh Lee, Jaw-Ching Wu.   

Abstract

BACKGROUND: Epidemiologic studies have identified cholecystectomy as a possible risk factor for cancers in Western countries. The aim of this study was to estimate the risk of hepato-biliary cancer after cholecystectomy in Taiwan.
METHODS: Based on the Taiwan National Health Insurance Research Database, 2,590 cholecystectomized patients without prior cancers in the period 1996-2008 were identified from a cohort dataset of 1,000,000 randomly sampled individuals. The standard incidence ratio (SIR) of each cancer was calculated.
RESULTS: After a median follow-up of 4.82 years, 67 liver cancer and 17 biliary tract cancer patients were diagnosed. Patients who received cholecystectomy had higher risks of liver cancer (SIR, 3.29) and biliary tract cancer (SIR, 8.50). Cholecystectomized patients aged ≤60 years had higher risks of liver cancer (SIR, 11.14) and biliary tract cancer (SIR, 55.86) compared to those aged >60 years (SIR, 2.31 and 5.67). Female cholecystectomized patients had higher risks of liver cancer (SIR, 4.18) and biliary tract cancer (SIR, 10.56) than males (SIR, 2.96 and 7.26). Cholecystectomized patients with cirrhosis had higher SIR of liver cancer than patients without cirrhosis (SIR, 33.84 vs. 1.41).
CONCLUSIONS: Cholecystectomy may be associated with an increased risk of hepato-biliary cancer. Further and regular surveillance should be performed on such patients.

Entities:  

Mesh:

Year:  2012        PMID: 23188223     DOI: 10.1007/s11605-012-2090-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  43 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study.

Authors:  J-C Luo; H-B Leu; M-C Hou; C-C Huang; H-C Lin; F-Y Lee; F-Y Chang; W-L Chan; S-J Lin; J-W Chen
Journal:  Aliment Pharmacol Ther       Date:  2012-07-23       Impact factor: 8.171

Review 3.  Biology of aging and cancer.

Authors:  Vladimir N Anisimov
Journal:  Cancer Control       Date:  2007-01       Impact factor: 3.302

4.  Association between cholecystectomy and adenocarcinoma of the esophagus.

Authors:  J Freedman; W Ye; E Näslund; J Lagergren
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

5.  Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey.

Authors:  Chien-Hua Chen; Min-Ho Huang; Jee-Chun Yang; Chiu-Kue Nien; Gina Doskey Etheredge; Chi-Chieh Yang; Yung-Hsiang Yeh; Hurng-Sheng Wu; Der-Aur Chou; Sen-Kou Yueh
Journal:  J Gastroenterol Hepatol       Date:  2006-11       Impact factor: 4.029

6.  Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis.

Authors:  Jiing-Chyuan Luo; Hsin-Bang Leu; Kuang-Wei Huang; Chin-Chou Huang; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Shou-Dong Lee
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

7.  Cholecystectomy as a risk factor for oesophageal adenocarcinoma.

Authors:  J Lagergren; F Mattsson
Journal:  Br J Surg       Date:  2011-05-17       Impact factor: 6.939

8.  The prevalence and incidence of cholecystolithiasis in patients with chronic liver diseases: a prospective study.

Authors:  I S Sheen; Y F Liaw
Journal:  Hepatology       Date:  1989-04       Impact factor: 17.425

9.  Risk of extrahepatic bileduct cancer after cholecystectomy.

Authors:  A Ekbom; C C Hsieh; J Yuen; D Trichopoulos; J K McLaughlin; S J Lan; H O Adami
Journal:  Lancet       Date:  1993-11-20       Impact factor: 79.321

10.  Longitudinal study of gall stone prevalence at necropsy.

Authors:  T Bates; M Harrison; D Lowe; C Lawson; N Padley
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

View more
  8 in total

1.  Gallstones and risk of cancers of the liver, biliary tract and pancreas: a prospective study within two U.S. cohorts.

Authors:  Xiao Luo; Wanshui Yang; Amit D Joshi; Kana Wu; Tracey G Simon; Chen Yuan; Lina Jin; Lu Long; Mi Na Kim; Chun-Han Lo; Xing Liu; Thomas A Abrams; Brian M Wolpin; Andrew T Chan; Edward L Giovannucci; Xuehong Zhang
Journal:  Br J Cancer       Date:  2022-06-17       Impact factor: 9.075

2.  Gallstones and the Risk of Gallbladder Cancer Mortality: A Cohort Study.

Authors:  Seungho Ryu; Yoosoo Chang; Kyung Eun Yun; Hyun-Suk Jung; Jun Ho Shin; Hocheol Shin
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

3.  Risk of primary liver cancer associated with gallstones and cholecystectomy: a meta-analysis.

Authors:  Yanqiong Liu; Yu He; Taijie Li; Li Xie; Jian Wang; Xue Qin; Shan Li
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

4.  Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinoma.

Authors:  Tao Li; Shu-Kang Wang; Xu-Ting Zhi; Jian Zhou; Zhao-Ru Dong; Zong-Li Zhang; Hui-Chuan Sun; Qing-Hai Ye; Jia Fan
Journal:  Sci Rep       Date:  2016-06-20       Impact factor: 4.379

5.  High Mortality of Cirrhotic Patients With End-Stage Renal Disease.

Authors:  Tsung-Hsing Hung; Chen-Chi Tsai; Kuo-Chih Tseng; Chih -Wei Tseng; Yu-Hsi Hsieh; Chih-Chun Tsai; Hsing-Feng Lee
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

6.  Cholecystectomy is associated with higher risk of recurrence after microwave ablation of hepatocellular carcinoma: a propensity score matching analysis.

Authors:  Hongcai Yang; Yi Yang; Jianping Dou; Rui Cui; Zhigang Cheng; Zhiyu Han; Fangyi Liu; Xiaoling Yu; Xiang Zhou; Jie Yu; Ping Liang
Journal:  Cancer Biol Med       Date:  2020-05-15       Impact factor: 4.248

7.  Cholelithiasis and the risk of liver cancer: results from cohort studies of 134,546 Chinese men and women.

Authors:  Emily Vogtmann; Xiao-Ou Shu; Hong-Lan Li; Wong-Ho Chow; Gong Yang; Bu-Tian Ji; Hui Cai; Chang Yu; Yu-Tang Gao; Wei Zheng; Yong-Bing Xiang
Journal:  J Epidemiol Community Health       Date:  2014-02-26       Impact factor: 3.710

8.  Concurrent Cholecystectomy Is Associated with a Lower Risk of Recurrence after Curative Resection in Early-Stage Hepatocellular Carcinoma: A 10 Year Observational Single-Center Study.

Authors:  Yu-Syuan Chen; Shih-Yu Yang; Pei-Ming Wang; Chih-Chi Wang; Chee-Chien Yong; Ding-Wei Chen; Yueh-Wei Liu; Ching-Hui Chuang; Pao-Yuan Huang; Chih-Chien Yao; Yen-Po Lin; Ming-Chao Tsai
Journal:  J Pers Med       Date:  2021-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.